Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study reviewed trichoscopic images to assess hair loss, finding that ayurvedic signs (lakshanas) aligned with modern trichoscopic parameters, potentially aiding accurate diagnosis and management of hair conditions.

This study found that combining platelet-rich plasma with topical minoxidil improved hair density and patient satisfaction in androgenetic alopecia patients more than minoxidil alone, with no serious adverse events reported.

In this study, researchers investigated the alignment of trichoscopic findings with ayurvedic signs (lakshanas) for diagnosing hair loss, suggesting that integrating these perspectives could enhance diagnostics and management of hair and scalp conditions.

This study reviewed existing literature on mesotherapy as a treatment for androgenetic alopecia, finding that it may improve hair density and thickness with generally mild side effects, but emphasized variability in study designs limits the strength of these conclusions.

This case study reported that a male patient with advanced androgenetic alopecia showed sustained improvements in hair density and quality of life after receiving individualized homeopathic treatment and regenerative hair therapy.

This study found a higher prevalence of lipid abnormalities in individuals with androgenetic alopecia, especially in severe cases, highlighting the need for early screening and treatment to prevent cardiovascular complications.

This mini-review examines ethnopharmacological approaches to manage hair loss in postmenopausal women, highlighting promising botanical remedies like saw palmetto, rosemary oil, and ginseng. The authors underscore a need for more interdisciplinary trials and focus on traditional remedies' multifaceted benefits, while noting gaps in menopausal-specific evidence.

This analysis concluded that mesenchymal stem cell-derived exosome therapy may offer a promising and safe approach for hair restoration, especially in androgenetic alopecia, despite limitations in study consistency and size.

This review found that low-dose oral Minoxidil may be a viable alternative to topical Minoxidil for treating androgenetic alopecia, offering similar efficacy but with better adherence and different side effect profiles; consideration of patient-specific factors is important for treatment choice.

In this research, a thorough review of hair loss issues and treatments identified the effectiveness of minoxidil and finasteride for alopecia in the scalp's vertex region, but noted concerns about their potential long-term effects, leading to increased interest in herbal therapies.

In this observational study, researchers found that acute telogen effluvium, a form of temporary hair loss, occurred in 80 patients following COVID-19 infection, with 70 showing a significant decrease in hair density and trichoscopic signs like peripilar sign and yellow dots.

This study suggests that a combination of blue light photobiomodulation and biomimetic peptide infiltrations may effectively increase hair density in patients with androgenetic alopecia.

This study found that platelet-rich plasma therapy significantly increased hair diameter and density in male androgenetic alopecia patients over six months, particularly in those with AGA durations up to five years.

In this study, dutasteride was found to be effective and safe in treating androgenetic alopecia in men who did not respond to finasteride, with improvements observed in hair loss and quality over 24 weeks.

This clinical trial found that combining 678 nm helmet-type low-level laser therapy with topical minoxidil 5% significantly increased hair density and patient satisfaction in men with androgenetic alopecia, compared to using minoxidil alone. Both treatments were well tolerated.

This study found that using 'moha: 5-in-1' hair oil for 8 weeks significantly reduced hair fall, increased hair growth rate and thickness, and decreased scalp dandruff among healthy adults with alopecia, with no adverse effects reported.

This study found that using Urtica cannabina extract shampoo led to increased levels of copper, zinc, and iodine in the scalp hair of Mongolian women, along with improvements in hair growth, diameter, and density compared to a regular shampoo.

This study demonstrated that a daily oral supplement of 1000 mg Kera-Diet® improved hair and nail conditions in women experiencing acute telogen effluvium and brittle nail syndrome over three months.

In this study, researchers found that supplementation with L-cystine, either alone or with a keratin hydrolysate, significantly improved hair density, hair and nail brightness, and nail growth in women experiencing acute telogen effluvium and brittle nail syndrome over three months.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

In this study, researchers reported that IL-17C plays a key pro-inflammatory role in human skin diseases and may be a promising therapeutic target for inflammatory skin conditions.

Intermittent iron and nutritional supplements can help reduce hair loss.

PRP injection therapy shows promise for treating hair loss, increasing hair count and thickness with minimal side effects.

Postpartum hair loss usually stops within 4-6 months.

This study found that Rosebay extract significantly reduced dandruff and sebum production, suggesting it may be an effective anti-dandruff ingredient as a complement or alternative to antifungal treatments.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

This review discusses common mistakes in follicular unit transplantation and provides guidance for practitioners to enhance patient outcomes, but reports no new clinical results.

This workshop review from the Australian Hair and Wool Research Society discusses findings in cutaneous biology and endocrinology but presents no new research results.

The author reports that an evaluation system for assessing candidacy in alopecia-reducing procedures significantly decreased unsuitable surgeries while maintaining consistently good outcomes.

This article proposes a standardized naming system for areas of the balding scalp to improve communication among hair restoration professionals, but it reports no clinical results.